These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 38940421)

  • 21. Multiplexed strategies toward clinical translation of extracellular vesicles.
    Song J; Song B; Yuan L; Yang G
    Theranostics; 2022; 12(15):6740-6761. PubMed ID: 36185609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the clinical transition of engineered exosomes designed for intracellular delivery of therapeutic proteins.
    Kim M; Choi H; Jang DJ; Kim HJ; Sub Y; Gee HY; Choi C
    Stem Cells Transl Med; 2024 Jul; 13(7):637-647. PubMed ID: 38838263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent Advancements in the Loading and Modification of Therapeutic Exosomes.
    Xu M; Yang Q; Sun X; Wang Y
    Front Bioeng Biotechnol; 2020; 8():586130. PubMed ID: 33262977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. State-of-the-art exosome loading and functionalization techniques for enhanced therapeutics: a review.
    Donoso-Quezada J; Ayala-Mar S; González-Valdez J
    Crit Rev Biotechnol; 2020 Sep; 40(6):804-820. PubMed ID: 32605394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineered and Mimicked Extracellular Nanovesicles for Therapeutic Delivery.
    Poinsot V; Pizzinat N; Ong-Meang V
    Nanomaterials (Basel); 2024 Apr; 14(7):. PubMed ID: 38607173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exosome-like systems: Nanotechnology to overcome challenges for targeted cancer therapies.
    García-Fernández J; Fuente Freire M
    Cancer Lett; 2023 May; 561():216151. PubMed ID: 37001751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current strategies in tailoring methods for engineered exosomes and future avenues in biomedical applications.
    Mishra A; Singh P; Qayoom I; Prasad A; Kumar A
    J Mater Chem B; 2021 Aug; 9(32):6281-6309. PubMed ID: 34286815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System.
    Li T; Li X; Han G; Liang M; Yang Z; Zhang C; Huang S; Tai S; Yu S
    Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.
    Rahbarghazi R; Jabbari N; Sani NA; Asghari R; Salimi L; Kalashani SA; Feghhi M; Etemadi T; Akbariazar E; Mahmoudi M; Rezaie J
    Cell Commun Signal; 2019 Jul; 17(1):73. PubMed ID: 31291956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
    Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineering Exosomes for Therapeutic Applications: Decoding Biogenesis, Content Modification, and Cargo Loading Strategies.
    Bahadorani M; Nasiri M; Dellinger K; Aravamudhan S; Zadegan R
    Int J Nanomedicine; 2024; 19():7137-7164. PubMed ID: 39050874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents.
    Lin Y; Lu Y; Li X
    J Drug Target; 2020 Feb; 28(2):129-141. PubMed ID: 31280623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineered Exosomes as Theranostic Platforms for Cancer Treatment.
    Yang X; Xie X; Liu S; Ma W; Zheng Z; Wei H; Yu CY
    ACS Biomater Sci Eng; 2023 Oct; 9(10):5479-5503. PubMed ID: 37695590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering exosomes as refined biological nanoplatforms for drug delivery.
    Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
    Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer.
    Lee YJ; Shin KJ; Chae YC
    Exp Mol Med; 2024 Apr; 56(4):877-889. PubMed ID: 38580812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in extracellular vesicles for therapeutic cargo delivery.
    Kim HI; Park J; Zhu Y; Wang X; Han Y; Zhang D
    Exp Mol Med; 2024 Apr; 56(4):836-849. PubMed ID: 38556545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of exosome engineering modification in targeted delivery of therapeutic drugs.
    Wang Y; Jiang M; Zheng X; He Y; Ma X; Li J; Pu K
    Biochem Pharmacol; 2023 Sep; 215():115691. PubMed ID: 37481135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineering exosomes for targeted drug delivery.
    Liang Y; Duan L; Lu J; Xia J
    Theranostics; 2021; 11(7):3183-3195. PubMed ID: 33537081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted therapeutic delivery using engineered exosomes and its applications in cardiovascular diseases.
    Xitong D; Xiaorong Z
    Gene; 2016 Jan; 575(2 Pt 2):377-384. PubMed ID: 26341056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Native and engineered exosomes for inflammatory disease.
    Ma X; Liu B; Fan L; Liu Y; Zhao Y; Ren T; Li Y; Li Y
    Nano Res; 2023; 16(5):6991-7006. PubMed ID: 36591564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.